PHILADELPHIA, PA — As vaccination gaps persist across the United States, GSK announced it has awarded $2 million in grants to 16 nonprofit organizations nationwide, backing community-driven efforts to ...
GSK is funding public health organizations working to address US adult immunization gaps and increase community vaccine education, outreach and access These grants are part of GSK’s COiMMUNITY ...
GSK supports seasonal flu immunization in the US by shipping FLULAVAL (Influenza Vaccine) and FLUARIX (Influenza Vaccine) in advance of flu season PHILADELPHIA--(BUSINESS WIRE)-- GSK plc (LSE/NYSE: ...
GSK and the National Senior Games team up to spotlight RSV risk, prevention, and the power of proactive health conversations National TV special “Redefining Aging” to launch in September, spotlighting ...
Pharmaceutical Technology on MSN
GSK’s oncology and HIV drugs drive 7% sales rise in 2025
The company is hoping that its accelerated R&D strategy and new launches will help offset the impact of upcoming patent expiries within its portfolio.
Sixteen organizations, awarded funding in 2025, are taking innovative, local approaches to boosting vaccination in communities across the US Grant recipients’ projects aim to modernize outreach ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results